跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NINLARO CAPSULES 2.3MG - PPB Drug Approval Details
Approvals
/
PPB
/
NINLARO CAPSULES 2.3MG
Approved
STANDARD
NINLARO CAPSULES 2.3MG
TAKEDA PHARMACEUTICALS (HONG KONG) LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
a01c2694ecad7475
Company
TAKEDA PHARMACEUTICALS (HONG KONG) LIMITED
Type
Standard
Approval Details
Approval Id
a01c2694ecad7475
Product Name
NINLARO CAPSULES 2.3MG
Drug Hk Name
NINLARO CAPSULES 2.3MG
Registration Code
HK-65570
Company Name
TAKEDA PHARMACEUTICALS (HONG KONG) LIMITED
Company Detail Path
/organization/takeda-pharmaceuticals-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2018-01-29
Company Address
23/F & 24/F, EAST EXCHANGE TOWER, 38 LEIGHTON ROAD, CAUSEWAY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
a01c2694ecad7475
Type
Standard
Back to PPB Approvals